Open AccessUpdated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer
Author(s) -
R.M. Connolly,
J.P. Leal,
L. Solnes,
Chuen-Hsuan Huang,
A. Carpenter,
K. Gaffney,
V. Abramson,
Lisa A. Carey,
M.C. Liu,
M. Rimawi,
J. Specht,
A.M. Storniolo,
V. Valero,
C. Vaklavas,
I.E. Krop,
E.P. Winer,
M. Camp,
R.S. Miller,
A.C. Wolff,
A. Cimino-Mathews,
B.H. Park,
R.L. Wahl,
V. Stearns
Publication year - 2021
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/brnf-1571
Subject(s) - pertuzumab , trastuzumab , oncology , breast cancer , medicine , pathological , cancer